Electrical bioimpedance for hypertension NCD
This article was originally published in The Gray Sheet
Executive Summary
Thoracic electrical bioimpedance (TEB) for treating drug-resistant hypertension is left to local carrier discretion, CMS states in an 1Aug. 7 national coverage determination decision memo. On the same day, the agency issued a national non-coverage policy for TEB in managing all other forms of hypertension. Six indications of TEB are already covered under an NCD (2"The Gray Sheet" Feb. 8, 1999, p. 7). CardioDynamics offers the BioZ impedance cardiography (ICG) test...